Mechanisms of GII.4 norovirus evolution

Trends in Microbiology

Volumn 19, Issue 5, 2011, Pages 233-240

  Bull, Rowena A ^a   White, Peter A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN P2; VIRUS RNA;

ANTIGEN BINDING; BACTERIAL GENETICS; CLINICAL FEATURE; EPIDEMIC; GASTROENTERITIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HERD IMMUNITY; HUMAN; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PANDEMIC; PHYLOGENY; POPULATION SIZE; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; RNA SEQUENCE; SEROPREVALENCE; VIRAL GENETICS; VIRUS CHARACTERIZATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

CALICIVIRIDAE INFECTIONS; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GENOTYPE; HUMANS; NOROVIRUS; VIRULENCE; VIRUS ATTACHMENT; VIRUS REPLICATION;

MIRIDAE; NOROVIRUS;

EID: 79955476677     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2011.01.002     Document Type: Review

References (98)

1. Pybus O.G., Rambaut A. Evolutionary analysis of the dynamics of viral infectious disease. Nat. Rev. Genet. 2009, 10:540-550.
2. Bok K., et al. Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J. Virol. 2009, 83:11890-11901.
3. Bull R.A., et al. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 2010, 6:e1000831.
4. Siebenga J.J., et al. Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog. 2010, 6:e1000884.
5. Patel M.M., et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 2008, 14:1224-1231.
6. Tu E.T., et al. Norovirus excretion in an aged-care setting. J. Clin. Microbiol. 2008, 46:2119-2121.
7. Bruggink L.D., Marshall J.A. Molecular changes associated with altered patterns of norovirus outbreak epidemics in Victoria, Australia, in 2006 to 2007. J. Clin. Microbiol. 2010, 48:857-861.
8. Eden J.S., et al. Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008. J. Clin. Virol. 2010, 49:265-271.
9. Kroneman A., et al. Data quality of 5 years of central norovirus outbreak reporting in the European Network for food-borne viruses. J. Public Health (Oxford, England) 2008, 30:82-90.
10. Siebenga J.J., et al. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J. Infect. Dis. 2009, 200:802-812.
11. Zheng D.P., et al. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J. Clin. Microbiol. 2010, 48:168-177.
12. Tu E.T., et al. Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin. Infect. Dis. 2008, 46:413-420.
13. Atmar R.L., Estes M.K. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. N. Am. 2006, 35:275-290. viii.
14. Green K.Y., et al. Human calicivirus. Fields Virology 2001, 841-874. Lippincott Williams & Wilkins. 4th edn. D.M. Knipe, P.M. Howley (Eds.).
15. Glass P.J., et al. Norwalk virus open reading frame 3 encodes a minor structural protein. J. Virol. 2000, 74:6581-6591.
16. Pletneva M.A., et al. The genome of hawaii virus and its relationship with other members of the caliciviridae. Virus Genes 2001, 23:5-16.
17. Chen R., et al. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8048-8053.
18. Prasad B.V., et al. X-ray crystallographic structure of the Norwalk virus capsid. Science 1999, 286:287-290.
19. Tan M., et al. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J. Virol. 2004, 78:6233-6242.
20. Siebenga J.J., et al. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J. Virol. 2007, 81:9932-9941.
21. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol. 2005, 79:14017-14030.
22. Zheng D.P., et al. Norovirus classification and proposed strain nomenclature. Virology 2006, 346:312-323.
23. Patel M.M., et al. Noroviruses: a comprehensive review. J. Clin. Virol. 2009, 44:1-8.
24. Green K.Y., et al. Taxonomy of the caliciviruses. J. Infect. Dis. 2000, 181(I Suppl. 2):S322-330.
25. Wang Q.H., et al. Porcine noroviruses related to human noroviruses. Emerg. Infect. Dis. 2005, 11:1874-1881.
26. Oliver S.L., et al. Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J. Virol. 2003, 77:2789-2798.
27. Wolf S., et al. Molecular detection of norovirus in sheep and pigs in New Zealand farms. Vet. Microbiol. 2009, 133:184-189.
28. Martella V., et al. Norovirus in captive lion cub (Panthera leo). Emerg. Infect. Dis. 2007, 13:1071-1073.
29. Martella V., et al. Detection and molecular characterization of a canine norovirus. Emerg. Infect. Dis. 2008, 14:1306-1308.
30. Fankhauser R.L., et al. Epidemiologic and molecular trends of 'Norwalk-like viruses' associated with outbreaks of gastroenteritis in the United States. J. Infect. Dis. 2002, 186:1-7.
31. Karst S.M., et al. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003, 299:1575-1578.
32. Mesquita J.R., et al. Novel norovirus in dogs with diarrhea. Emerg. Infect. Dis. 2010, 16:980-982.
33. Scipioni A., et al. Animal noroviruses. Vet. J. 2008, 178:32-45.
34. Mattison K., et al. Human noroviruses in swine and cattle. Emerg. Infect. Dis. 2007, 13:1184-1188.
35. Farkas T., et al. Seroprevalence of noroviruses in swine. J. Clin. Microbiol. 2005, 43:657-661.
36. Hutson A.M., et al. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J. Virol. 2003, 77:405-415.
37. Kapikian A.Z., et al. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J. Virol. 1972, 10:1075-1081.
38. Bull R.A., et al. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J. Clin. Microbiol. 2006, 44:327-333.
39. Ratcliff R.M., et al. Sensitive detection of RNA viruses associated with gastroenteritis by a hanging-drop single-tube nested reverse transcription-PCR method. J. Clin. Microbiol. 2002, 40:4091-4099.
40. Wright P.J., et al. Small round-structured (Norwalk-like) viruses and classical human caliciviruses in southeastern Australia, 1980-1996. J. Med. Virol. 1998, 55:312-320.
41. Donaldson E.F., et al. Viral shape-shifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 2010, 8:231-241.
42. Lindesmith L.C., et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008, 5:e31.
43. Motomura K., et al. Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J. Virol. 2010, 84:8085-8097.
44. Coiras M.T., et al. Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in spain from 1996 to 2000. Arch. Virol. 2001, 146:2133-2147.
45. De Jong J.C., et al. Influenza virus: a master of metamorphosis. J. Infect. 2000, 40:218-228.
46. Koelle K., et al. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006, 314:1898-1903.
47. Hay A.J., et al. The evolution of human influenza viruses. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2001, 356:1861-1870.
48. Lopman B., et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004, 363:682-688.
49. Fankhauser R.L., et al. Molecular epidemiology of 'Norwalk-like viruses' in outbreaks of gastroenteritis in the United States. J. Infect. Dis. 1998, 178:1571-1578.
50. Dingle K.E. Mutation in a Lordsdale norovirus epidemic strain as a potential indicator of transmission routes. J. Clin. Microbiol. 2004, 42:3950-3957.
51. Vipond I.B., et al. National epidemic of Lordsdale Norovirus in the UK. J. Clin. Virol. 2004, 30:243-247.
52. Widdowson M.A., et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus - United States, 2002. J. Infect. Dis. 2004, 190:27-36.
53. Tan M., Jiang X. Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog. 2010, 6:e1000983.
54. Lindesmith L., et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003, 9:548-553.
55. Huang P., et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 2005, 79:6714-6722.
56. Tan M., Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol. 2005, 13:285-293.
57. Bu W., et al. Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 2008, 82:5340-5347.
58. Cao S., et al. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 2007, 81:5949-5957.
59. Choi J.M., et al. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9175-9180.
60. Tan M., et al. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS ONE 2009, 4:e5058.
61. Le Pendu J. Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv. Exp. Med. Biol. 2004, 554:135-143.
62. Yang Y., et al. Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J. Virol. 2010, 84:9595-9607.
63. Donaldson E.F., et al. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol. Rev. 2008, 225:190-211.
64. Elena S.F., Sanjuan R. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J. Virol. 2005, 79:11555-11558.
65. Nordgren J., et al. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. Emerg. Infect. Dis. 2010, 16:81-87.
66. Holmes E.C. Error thresholds and the constraints to RNA virus evolution. Trends Microbiol. 2003, 11:543-546.
67. Bailly J.L., et al. Phylogeography of circulating populations of human echovirus 30 over 50 years: nucleotide polymorphism and signature of purifying selection in the VP1 capsid protein gene. Infect. Genet. Evol. 2009, 9:699-708.
68. Haydon D.T., et al. Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates. Genetics 2001, 157:7-15.
69. Mayrose I., et al. Towards realistic codon models: among site variability and dependency of synonymous and non-synonymous rates. Bioinformatics 2007, 23:i319-327.
70. Wolf Y.I., et al. Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus. Biol. Direct. 2006, 1:34.
71. Miralles R., et al. Diminishing returns of population size in the rate of RNA virus adaptation. J. Virol. 2000, 74:3566-3571.
72. Estes M.K., et al. Noroviruses everywhere: has something changed?. Curr. Opin. Infect. Dis. 2006, 19:467-474.
73. Johnson P.C., et al. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 1990, 161:18-21.
74. Chachu K.A., et al. Antibody is critical for the clearance of murine norovirus infection. J. Virol. 2008, 82:6610-6617.
75. Lindesmith L.C., et al. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J. Virol. 2010, 84:1800-1815.
76. Ball J.M., et al. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology 1999, 117:40-48.
77. Matsui S.M., Greenberg H.B. Immunity to calicivirus infection. J. Infect. Dis. 2000, 181(Suppl. 2):S331-335.
78. Cannon J.L., et al. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J. Virol. 2009, 83:5363-5374.
79. Parrino T.A., et al. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 1977, 297:86-89.
80. Reeck A., et al. Serological correlate of protection against norovirus-induced gastroenteritis. J. Infect. Dis. 2010, 202:1212-1218.
81. Bull R.A., et al. Norovirus recombination. J. Gen. Virol. 2007, 88:3347-3359.
82. Phan T.G., et al. Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in Japan. J. Med. Virol. 2006, 78:971-978.
83. Lindesmith L.C., et al. Norovirus GII.4 strain antigenic variation. J. Virol. 2011, 85:231-242.
84. Drake J.W., Holland J.J. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13910-13913.
85. Ortin J., Parra F. Structure and function of RNA replication. Annu. Rev. Microbiol. 2006, 60:305-326.
86. Roossinck M.J. Mechanisms of plant virus evolution. Annu. Rev. Phytopathol. 1997, 35:191-209.
87. Pugachev K.V., et al. High fidelity of yellow fever virus RNA polymerase. J. Virol. 2004, 78:1032-1038.
88. Domingo E., et al. Basic concepts in RNA virus evolution. FASEB J. 1996, 10:859-864.
89. Holland J.J., et al. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 1990, 64:3960-3962.
90. Domingo E., et al. Quasispecies dynamics and RNA virus extinction. Virus Res. 2005, 107:129-139.
91. Manrubia S.C., et al. High mutation rates, bottlenecks, and robustness of RNA viral quasispecies. Gene 2005, 347:273-282.
92. Iritani N., et al. Epidemic of genotype GII.2 noroviruses during spring 2004 in Osaka City, Japan. J. Clin. Microbiol. 2008, 46:2406-2409.
93. Mathijs E., et al. Experimental evidence of recombination in murine noroviruses. J. Gen. Virol. 2010, 91:2723-2733.
94. Kirkegaard K., Baltimore D. The mechanism of RNA recombination in poliovirus. Cell 1986, 47:433-443.
95. McCahon D., Slade W.R. A sensitive method for the detection and isolation of recombinants of foot-and-mouth disease virus. J. Gen. Virol. 1981, 53:333-342.
96. Bull R.A., et al. Norovirus recombination in ORF1/ORF2 overlap. Emerg. Infect. Dis. 2005, 11:1079-1085.
97. Rohayem J., et al. Evidence of recombination in the norovirus capsid gene. J. Virol. 2005, 79:4977-4990.
98. Kamel A.H., et al. Predominance and circulation of enteric viruses in the region of Greater Cairo, Egypt. J. Clin. Microbiol. 2009, 47:1037-1045.